Ligand id: 366

Name: clidinium

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 5
Topological polar surface area 46.53
Molecular weight 352.19
XLogP 5.04
No. Lipinski's rules broken 1

Molecular properties generated using the CDK

No information available.
Summary of Clinical Use
Used in the treatment of peptic ulcers, irritable bowel syndrome and the relief of abdominal or stomach spasms or cramps. US FDA marketing approval for clidinium (trade name Quarzan®) has been discontinued.
Mechanism Of Action and Pharmacodynamic Effects
Mechanism of action is thought to be primarily due to inhibition of the muscarinic actions of acetylcholine on M1 muscarinic receptors located postganglionically at parasympathetic neuroeffector junctions.